Former chairman and CEO, MedAlliance
Appears in 1 story
Led the company that developed SELUTION SLR before its acquisition by Cordis
The FDA on September 21 approved the first drug-eluting balloon for coronary use in the United States. Cordis' SELUTION SLR expands inside a narrowed artery, releases the drug sirolimus into the vessel wall for up to 90 days, and is removed — no permanent implant stays behind.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
